James Stillman Hanson
2018
In 2018, James Stillman Hanson earned a total compensation of $4.9M as General Counsel at G1 Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $71,094 |
|---|---|
| Option Awards | $4,654,469 |
| Salary | $169,271 |
| Other | $3,750 |
| Total | $4,898,584 |
Hanson received $4.7M in option awards, accounting for 95% of the total pay in 2018.
Hanson also received $71.1K in non-equity incentive plan, $169.3K in salary and $3.8K in other compensation.
Rankings
In 2018, James Stillman Hanson's compensation ranked 2,071st out of 14,244 executives tracked by ExecPay. In other words, Hanson earned more than 85.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,071 out of 14,244 | 86th |
Division Manufacturing | 747 out of 5,762 | 87th |
Major group Chemicals And Allied Products | 248 out of 2,125 | 88th |
Industry group Drugs | 198 out of 1,814 | 89th |
Industry Pharmaceutical Preparations | 152 out of 1,388 | 89th |
Source: SEC filing on April 30, 2019.
Hanson's colleagues
We found five more compensation records of executives who worked with James Stillman Hanson at G1 Therapeutics in 2018.
2018
John Demaree
G1 Therapeutics
Chief Commercial Officer
2018
Terry Murdock
G1 Therapeutics
Chief Operating Officer
2018
Mark Velleca
G1 Therapeutics
Chief Executive Officer
2018
Rajesh Malik
G1 Therapeutics
Chief Medical Officer
2018
Barclay Phillips
G1 Therapeutics